-
Mashup Score: 3
Little is known about the evidence to support prescription digital therapeutics, which are digital tools that rely primarily on software for diagnosis or treatment that have indications for use regulated by the Food and Drug Administration (FDA) and require a clinician’s prescription. We conducted the first retrospective cross-sectional analysis of clinical studies of twenty prescription digital therapeutics authorized by the FDA and available on the market as of November 2022. Our analysis found that just two prescription digital therapeutics had been evaluated in at least one study that was randomized and blinded and that used other rigorous standards of evidence. Two-thirds of clinical studies of prescription digital therapeutics were conducted on a postmarket basis, with less rigorous standards of evidence than the standards used in premarket studies. More than half of studies did not report data on participants’ race, and more than 80 percent did not report their ethnicity. More t
Source: www.healthaffairs.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0DTx Podcast with Eugene Borukhovich - 6 month(s) ago
Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing this industry.
Source: listen.podcasts.healthCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0
The multimillion-dollar distribution and marketing partnership comes amid a decline in funding for prescription digital therapeutic companies.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Big Health acquires prescription PDTx company Limbix - 9 month(s) ago
The San Francisco-based company will add Limbix’s SparkRx offering to its digital therapeutics portfolio.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Top 10 Takeaways from the June AMCP Summit on Prescription Digital Therapeutics | AMCP.org - 9 month(s) ago
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists and attendees from across the industry. Read 10 key takeaway points from the Summit.
Source: www.amcp.orgCategories: Latest Headlines, PayerTweet-
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists & attendees. From ranking formulary evaluation tools & resources to coverage design, explore highlights from the event: https://t.co/EUNpoItUZQ #pdts #digitaltherapeutics https://t.co/Q4tQ4Ph044
-
-
Mashup Score: 0The 3 Hottest Areas for Healthcare Generative AI - MedCity News - 9 month(s) ago
There are three key areas of the healthcare sector where generative AI is booming the most — in terms of both venture capital funding and the development of innovative technology — according to Anjalika Komatireddy, an analyst at CB Insights. During a recent webinar, she discussed the generative AI activity occurring in these three areas: care delivery and navigation, digital therapeutics and…
Source: MedCity NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Better Therapeutics wins FDA nod for diabetes digital therapeutic - 9 month(s) ago
Better Therapeutics (Nasdaq:BTTX) announced that the FDA authorized its AspyreRx prescription digital therapeutic for diabetes.
Source: Drug Delivery BusinessCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Exclusive: Digital Therapeutics Alliance, Healthware recommend digital therapeutics policy pathways in Europe - 9 month(s) ago
Alberta Spreafico, managing director of digital health and innovation at Healthware, shares how the report can guide companies’ go-to-market strategies for entering the European market.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0DTx Podcast with Eugene Borukhovich - 9 month(s) ago
Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing
Source: link.chtbl.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0DTx Podcast with Eugene Borukhovich - 9 month(s) ago
Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing
Source: link.chtbl.comCategories: Future of Medicine, Latest HeadlinesTweet
Clinical studies of prescription #DigitalTherapeutics often lack inclusivity, according to Sanket S. Dhruva of @UCSFMedicine & @SFVAMC + coauthors @RFRedberg @nxpatel & @jsross119. >50% of studies didn’t report on race & >80% didn’t report ethnicity. https://t.co/Qh1xb19wC6